EDGAR Filing Documents for 0001012168-98-000050

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0001012168-98-000050

Filing Date

1998-07-29

Accepted

1998-07-29 00:00:00

Documents

Group Members

ANDREW B. FREMDERDAVID I. COHENENRIQUE H. BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LLC /ADVFARALL

SROs

NASD

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO SCHEDULE 13D		SC 13D/A	71268
	Complete submission text file	0001012168-98-000050.txt		73891

Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111

Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132

FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address

Business Address 275 ARMAND FRAPPIER BOULEVARD LAVAL PROVICE QUEBEC A8 00000 5146811744

CLINICHEM DEVELOPMENT INC (Subject) CIK: 0001054396 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-54385 | Film No.: 98673463
SIC: 2834 Pharmaceutical Preparations